What to expect after tricuspid valve replacement? Long-term results
Authors:
- Kerem M. VuralKVKerem M. Vural
- Ilknur BaharIBIlknur Bahar
- Levent MaviogluLMLevent Mavioglu
- Ahmet SaritasASAhmet Saritas
- 1 August 2007
- journal article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 32 (2) , 296-300
Abstract
Current knowledge in long-term results of tricuspid valve replacement is limited. Present study reviews our experience from a consecutive series. Forty-two patients (16 male, 26 female; mean age: 33+/-15) underwent tricuspid valve replacement between March 1987 and December 2004. The etiology was rheumatic in 64%, Ebstein's anomaly in 31%, and endocarditis in 5%. Nineteen patients were in New York Heart Association (NYHA) Class III functional capacity (45%), and 13 in class IV (31%). Twenty patients (48%) underwent isolated tricuspid valve replacement. The remaining underwent combined (mitral and/or aortic) valve replacements. Tricuspid replacement device was mechanical in 31% and bioimplant in 69%. Hospital mortality was 26%. Rheumatic etiology, reoperation and elevated pulmonary artery pressure were associated with higher early mortality. The patients with decreased functional capacity (NYHA Class III/IV), congestive symptoms and rheumatic origin were more prone to low cardiac output development. The Kaplan-Meier survivals were 37% at 10 years and 30% at 15 years. The 10-year event-free survival was 31%. Elevated pulmonary artery pressure and rheumatic etiology unfavorably affected the long-term results. The average functional capacity in survivors improved significantly after operation. Any tricuspid disease not amenable to repair thus necessitating replacement is an unfortunate situation since both the short and long-term results of valve replacement are suboptimal in regard to those of left-sided valve replacements, probably due to different structural and geometrical characteristics of right ventricle and the low-pressure venous system hemodynamics. Etiology, clinical presentation and pulmonary vascular hemodynamics are major determinants of the outcome.Keywords
This publication has 8 references indexed in Scilit:
- Long-Term Clinical Results of Tricuspid Valve ReplacementThe Annals of Thoracic Surgery, 2006
- Long-Term Outcomes of Tricuspid Valve Replacement in the Current EraThe Annals of Thoracic Surgery, 2005
- Biological or mechanical prostheses in tricuspid position? a meta-analysis of intra-institutional resultsThe Annals of Thoracic Surgery, 2004
- Tricuspid valve replacement: an analysis of 25 years of experience at a single centerThe Annals of Thoracic Surgery, 2003
- Prosthetic replacement of tricuspid valve: bioprosthetic or mechanicalThe Annals of Thoracic Surgery, 2002
- Mechanical valves in tricuspid position: cause of thrombosis and preventionEuropean Journal of Cardio-Thoracic Surgery, 2001
- Tricuspid valve replacement with the St. Jude Medical valve: 19 years of experienceEuropean Journal of Cardio-Thoracic Surgery, 2000
- Tricuspid valve replacement: UK heart valve registry mid-term results comparing mechanical and biological prosthesesThe Annals of Thoracic Surgery, 1998